Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FA1PQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,920
Award facts
- Contract value 100% obligated
- $58,919.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,919.60 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of ENBREL 50 MG/ML SureClick auto-injectors, with completion scheduled for February 2, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen) providing corporate oversight. The order will be performed at the company's Conshohocken location and fulfills pharmaceutical supply requirements within the Defense Health Agency's medical procurement portfolio.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC enables the company to deliver a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. ENBREL is a biologic immunosuppressant used primarily for rheumatoid arthritis and other autoimmune conditions, representing the type of specialized pharmaceutical commodity essential to military treatment facilities and veteran healthcare systems that the IDC vehicle is designed to support.
Quick answers
Who was awarded contract SPE2DR26FA1PQ?
SPE2DR26FA1PQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FA1PQ worth?
The government has obligated $58,920 on SPE2DR26FA1PQ.
Is contract SPE2DR26FA1PQ an order under another contract?
Yes. SPE2DR26FA1PQ is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1PQ competed?
The extent of competition for SPE2DR26FA1PQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award